Latest Multiple drug resistance Stories
LONDON, November 5, 2014 /PRNewswire/ -- - Endolysin Staphefekt(TM) shown to kill Staphylococcus aureus, including MRSA - Emergence of
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc.
Oral presentation and nine posters presented at ICAAC WASHINGTON, Sept.
VIENNA, September 3, 2014 /PRNewswire/ -- New US Subsidiary to be located in the Philadelphia Area Nabriva Therapeutics AG, a biotechnology
Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with
According to a new report from BCC Research, the global market for systemic antibiotics is expected to grow to $41.2 billion by 2018 with a compound annual growth rate (CAGR) of 0.8% between 2013
On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1 SUNNYVALE, Calif., June 16, 2014 /PRNewswire/ -- Cepheid
Carbapenems Are Increasingly Being Deployed as Frontline Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., May 15, 2014 /PRNewswire/ -- Decision Resources Group
- Test Quickly Determines Colonization Risk of Multi-drug Resistant Microbes with Greater Accuracy than Currently Available Options - GAITHERSBURG, Md., May 15, 2014 /PRNewswire/ --
- A gift; a largess; a gratuity; a present; a dole.